V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) antibody

Details for Product No. ABIN966960, Supplier: Log in to see
Antigen
  • shep
  • I-REL
  • IREL
  • REL-B
  • XRelB
  • relb-A
  • GC-rich
  • avian reticuloendotheliosis viral (v-rel) oncogene related B
  • v-rel avian reticuloendotheliosis viral oncogene homolog B
  • v-rel reticuloendotheliosis viral oncogene homolog B
  • Relb
  • RELB
  • relb
Alternatives
anti-Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B antibody for Western Blotting
Reactivity
Human, Mouse (Murine), Rat (Rattus)
155
123
75
14
14
10
8
7
6
3
1
1
1
Host
Rabbit
158
7
Clonality
Polyclonal
Conjugate
Un-conjugated
5
5
3
3
3
3
3
3
3
3
3
3
3
3
Application
Immunohistochemistry (IHC)
121
40
36
27
22
10
5
4
2
2
2
2
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human RelB around the phosphorylation site of serine 552 (L-L-SP-P-G).
Specificity RelB (Ab-552) antibody detects endogenous levels of total RelB protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative Name RelB (RELB Antibody Abstract)
Pathways NF-kappaB Signaling, RTK Signaling
Application Notes WB: 1:500~1:1000.
Restrictions For Research Use only
Format Liquid
Concentration 100ug/100ul.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Product cited in: Pyz, Naidenko, Miyake, Yamamura, Berberich, Cardell, Kronenberg, Herrmann: "The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 176, Issue 12, pp. 7447-55, 2006 (PubMed).

Kaetzel: "The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces." in: Immunological reviews, Vol. 206, pp. 83-99, 2005 (PubMed).

Marienfeld, Berberich-Siebelt, Berberich, Denk, Serfling, Neumann: "Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control." in: Oncogene, Vol. 20, Issue 56, pp. 8142-7, 2002 (PubMed).

Did you look for something else?